1. Home
  2. AIRS vs AMRN Comparison

AIRS vs AMRN Comparison

Compare AIRS & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$5.31

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Logo Amarin Corporation plc

AMRN

Amarin Corporation plc

HOLD

Current Price

$14.42

Market Cap

304.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
AMRN
Founded
2012
1989
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
304.3M
IPO Year
2021
1998

Fundamental Metrics

Financial Performance
Metric
AIRS
AMRN
Price
$5.31
$14.42
Analyst Decision
Strong Sell
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
1.4M
67.6K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.00
EPS
N/A
N/A
Revenue
$151,818,000.00
$181,104,000.00
Revenue This Year
$5.19
N/A
Revenue Next Year
$5.32
$1.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
39.22
52 Week Low
$1.51
$11.27
52 Week High
$12.00
$20.90

Technical Indicators

Market Signals
Indicator
AIRS
AMRN
Relative Strength Index (RSI) 77.72 47.21
Support Level $2.40 $14.34
Resistance Level $6.90 $14.49
Average True Range (ATR) 0.44 0.49
MACD 0.09 -0.02
Stochastic Oscillator 88.39 32.02

Price Performance

Historical Comparison
AIRS
AMRN

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.

Share on Social Networks: